{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019817","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2022-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.559716+00:00","generated_at":"2026-06-24T11:58:08.433537+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PURE Bioscience raises $3.5M in private placement; CEO and directors participate","bullets":["Raised $3.5M via private placement of 23,333,332 shares at $0.15/share.","CEO Tom Y. Lee invested $3.26M through affiliates; directors Chen and Rendall invested $93,750 combined.","Proceeds for general corporate purposes including R&D, admin, working capital.","Shares issued under exemption from registration (Section 4(a)(2) and Rule 506).","Disinterested board members approved the transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019817","json":"https://secwatch.observer/filing/0001493152-22-019817.json","markdown":"https://secwatch.observer/filing/0001493152-22-019817.md","text":"https://secwatch.observer/filing/0001493152-22-019817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222019817/0001493152-22-019817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222019817/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T11:58:08.433537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}